Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Immunological and autoimmune disorders 9

Immunological and Autoimmune Disorders

medtech-news-for-siemens-paragon-28-pulnovo-endotronix-abbott

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Siemens Healthineers’s COVID-19 Antigen Self-Test; Paragon’s R3ACT Stabilization System; Pulnovo Medical’s PADN-CFDA trial; Endotronix’s PROACTIVE-HF trial; Abbott’s Proclaim XR SCS System; RTI Surgical spins off businesses

Siemens Healthineers received Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test by the FDA On December 29, 2021, Siemens Healthineers was granted Emergency Use Authorization (EUA) for its CLINITEST Rapid COVID-19 Antigen Self-Test by the United States Food and Drug Administration (FDA) for individuals age 14 and older or adult-collected samples from individual’s ages 2 to 13 years. The test is an easy-to-use nasal swab test intended to assist the rapid detection of SARS-CoV-2 by providing visually read results in just 15 minutes. From the starting of January 2022, the test is expected to be available nationwide through retail distrib...

Explore More...

Pharma News

Moderna’s COVID-19 vaccine; AcelRx buys TetraPhase; Breakthrough designation to Baricitinib

Pharma News

JNJ-6372 nabs FDA nods, Solid tumors treatment, Kevzara for COVID-19

Pharma News

First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed’s shares Soares

thyroid eye disease

Thyroid awareness month

Thyroid eye disease

Thyroid eye disease market: New therapies enter the TED market

Pharma News

Tepezza receives approval; a new way to treat Alzheimer’s

Pharma news

Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

Pharma News

Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

pharma news

Eli Lilly to acquire Dermira, Boehringer buys Enleofen’s IL-11 platform, Biogen acquires Pfizer’s Alzheimer’s drug

Egg Allergy Market

Egg Allergy Market: Second most common food allergy but no approved therapy

Allergic rhinitis market

Allergic rhinitis market: How common is Hay fever?

Allergic disease market

Global Allergic disease market

Pharma News

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

pharma news

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Pharma News

Cumberland’s methotrexate product gets approval in the US; Baker Brothers purchases stake in Kodiak’s KSI-301; Sanofi offloads Seprafilm unit to Baxter

Pharma News

Novartis buys Medicines; Blackstone Life Sciences and Ferring’s collaboration; Alexion’s Soliris (eculizumab) Approval;

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly